<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">S. aureus</italic> is often implicated in a wide array of community and hospital infections, including cutaneous and soft tissue infections, bacteremia, septic arthritis, osteomyelitis and necrotizing pneumonia (
 <xref rid="B56" ref-type="bibr" class="xref">Tong et al., 2015</xref>; 
 <xref rid="B9" ref-type="bibr" class="xref">Costa et al., 2016</xref>; 
 <xref rid="B43" ref-type="bibr" class="xref">Reddy et al., 2017</xref>). Due to indiscriminate use and its recurrent adaptation to clinical treatments over the last 50 years (
 <xref rid="B24" ref-type="bibr" class="xref">Hiramatsu et al., 2014</xref>), 
 <italic class="italic">S. aureus</italic> is always among the first bacterial species to develop resistance to multiple antibiotics (multiple drug resistance, MDR) (
 <xref rid="B55" ref-type="bibr" class="xref">Thurlow et al., 2012</xref>), including resistance to Î²-lactamics, aminoglycosides, macrolides, lincosamides, fluoroquinolones (FQs), chloramphenicol, sulfonamides, streptomycin, and tetracycline (
 <xref rid="B45" ref-type="bibr" class="xref">Schindler et al., 2013</xref>).
</p>
